As a receptor for CCL18, PITPNM3 highly expressed on epithelial and tumor cells in scRNA-seq data (Fig. 4A right panel) and indicated poor prognosis in microarray cohort (Fig. 4D). This evidence concerns the gene CCL18 and neoplasm.